Evidence map›Paper›PMID 34820387›Full record

ArticleFrontiers in cell and developmental biology2021

The Impact of Rare Human Variants on Barrier-To-Auto-Integration Factor 1 (Banf1) Structure and Function.

Maddison Rose, Bond Bai, Ming Tang, Chee Man Cheong, Sam Beard, Joshua T Burgess, Mark N Adams, Kenneth J O'Byrne, Derek J Richard, Neha S Gandhi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lipodystrophy-associated progeroid syndromes.Hormones (Athens, Greece) · 2022
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Maddison RoseQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Bond BaiQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Ming TangQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Chee Man CheongQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Sam BeardQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Joshua T BurgessQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Mark N AdamsQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Kenneth J O'ByrneQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Derek J RichardQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Neha S GandhiQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Emma BoldersonQueensland University of Technology (QUT), Cancer and Ageing Research Program, Centre for Genomics and Personalised Health, Translational Research Institute (TRI), Brisbane, QLD, Australia.
Translational Research Institute · AUQueensland University of Technology · AUPrincess Alexandra Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Barrier-to-Autointegration Factor 1 (Banf1/BAF) is a critical component of the nuclear envelope and is involved in the maintenance of chromatin structure and genome stability. Banf1 is a small DNA binding protein that is conserved amongst multicellular eukaryotes. Banf1 functions as a dimer, and binds non-specifically to the phosphate backbone of DNA, compacting the DNA in a looping process. The loss of Banf1 results in loss of nuclear envelope integrity and aberrant chromatin organisation. Significantly, mutations in Banf1 are associated with the severe premature ageing syndrome, Néstor-Guillermo Progeria Syndrome. Previously, rare human variants of Banf1 have been identified, however the impact of these variants on Banf1 function has not been explored. Here, using in silico modelling, biophysical and cell-based approaches, we investigate the effect of rare human variants on Banf1 structure and function. We show that these variants do not significantly alter the secondary structure of Banf1, but several single amino acid variants in the N- and C-terminus of Banf1 impact upon the DNA binding ability of Banf1, without altering Banf1 localisation or nuclear integrity. The functional characterisation of these variants provides further insight into Banf1 structure and function and may aid future studies examining the potential impact of Banf1 function on nuclear structure and human health.

Indexed as

BANF1DNA bindinghuman variantsnuclear envelopenuclear integrity

Identifiers

PMID34820387
PMCPMC8606531
OpenAlexW3214178793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.